Related Experiment Videos
Precursors of acetylcholine: considerations underlying their use in Tourette syndrome
Advances in Neurology
|January 1, 1982
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Real-world outcomes in patients with ALK-positive non-small cell lung cancer treated with crizotinib.
Current oncology (Toronto, Ont.)·2018
Real-world assessment of therapy changes, suboptimal treatment and associated costs in patients with ulcerative colitis or Crohn's disease.
Alimentary pharmacology & therapeutics·2014
Continuing education in psychotherapy as a method to attract and involve voluntary faculty in an academic department of psychiatry.
Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry·2014
Behavior therapy: other interventions for tic disorders.
Advances in neurology·2006
Treatment of aggression in Tourette syndrome.
Advances in neurology·2006
Treatment of co-morbid obsessive compulsive disorder, mood, and anxiety disorders.
Advances in neurology·2006
Neurobiology of basal ganglia and Tourette syndrome: basal ganglia circuits and thalamocortical outputs.
Advances in neurology·2006
Preclinical models relevant to Tourette syndrome.
Advances in neurology·2006
Biotinylated ε-Polylysine-Cyclodextrin-Coated Mesoporous Silica Nanoparticles for Targeted pH-Responsive Baicalin Delivery.
International journal of nanomedicine·2026
Binding of Epimedium Flavonoids to Human Serum Albumin: Insights from Spectroscopic and Molecular Docking Studies.
Iranian journal of pharmaceutical research : IJPR·2026
Fluorescence-based assay for evaluating SLC49A4 function: Identification of acriflavine as a probe substrate.
Journal of pharmaceutical sciences·2026
Use of cannabidiol products in Canada, United States, Australia, Aotearoa New Zealand, United Kingdom and Germany: products, sources and reasons for use.
The International journal on drug policy·2026